Searchable abstracts of presentations at key conferences in endocrinology

ea0065p429 | Thyroid | SFEBES2019

Audit of the use of TRAb testing first-line in the evaluation of hyperthyroidism

Ahmad Ehtasham , Gilbert Jackie

Graves’ disease (GD) is the most common cause of hyperthyroidism1 and is caused by stimulating autoantibodies to the TSH receptor (TRAb).2 TRAb assays have 98% sensitivity and 99% specificity 3 for GD and are recommended as the first-line cost-effective investigation to diagnosis the aetiology of hyperthyroidism and determine the risk of thyroid eye disease.4,5 In TRAb antibody negative patients, radionuclide imaging may be help...

ea0063p543 | Diabetes, Obesity and Metabolism 2 | ECE2019

Exploratory study into communication styles of diabetes healthcare professionals according to their patients numerical ability

Menon Vaishnavi , Harris Sophie , Brackenridge Anna , Amiel Stephanie

Background and aims: Type 1 diabetes mellitus (T1DM) requires daily self-management to mimic endocrine function, using numerical skills such as carbohydrate counting and interpreting nutritional information. Healthcare professionals (HCPs) rely on effective communication to relay information to people with T1DM to enable good self-care. Curricula for diabetes self-management education (DSME) courses require high-school level numerical skills. Eighty percent of adults in the Un...

ea0063p1153 | Reproductive Endocrinology 2 | ECE2019

Relationship and sexual experiences in young women with oestrogen deficiency: comparison between women with Turner syndrome and premature ovarian insufficiency

Attard Carol Cardona , Pimblett Antoinette , Puri Davina , Talaulikar Vikram , Davies Melanie , Conway Gerard

Background: Ages at first date and sexual encounter have been observed to be delayed in women with Turner’s syndrome (TS), with late presentation and delayed puberty induction being the main culprits. There is no equivalent data in women with premature ovarian insufficiency (POI).Objectives: We sought to assess whether age at start of oestrogen replacement therapy (ERT) and amenorrhoea status affected the age at first relationship and sexual experie...

ea0047oc8 | Spotlight on Neuroendocrine tumours | Theranostics2016

NETTER-1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-Dotatate: Efficacy, Safety, QoL Results and Subgroup Analysis

Strosberg Jonathan , Wolin E , Chasen B , Kulke M , Bushnell D , Caplin M , Baum R P , Kunz P , Hobday T , Hendifar A , Oberg K , Lopera Sierra M , Kwekkeboom D , Ruszniewski P , Krenning E

Background: Currently, there are limited therapeutic options for patients with advanced midgut neuroendocrine tumors progressing on first-line somatostatin analog therapy.Methods: NETTER-1 is the first phase III, randomized trial evaluating 177Lu-DOTA0-Tyr3-Octreotate (Lutathera®) in patients with progressive, somatostatin receptor positive midgut NETs. 230 patients were randomized to receive Lutathera 7.4...

ea0046p4 | (1) | UKINETS2016

Measurement of urinary 5-hydroxyindole acetic acid: correlation between spot versus 24-hour urine collection

Calanchini Matilde , Tadman Michael , Krogh Jesper , Fabbri Andrea , Grossman Ashley , Shine Brian

Introduction: In neuroendocrine tumours (NETs), the urinary concentration of the serotonin metabolite 5-hydroxyindole acetic acid (5-HIAA) is used to monitor disease progression or treatment response. The sensitivity and specificity in the presence of the carcinoid syndrome are approximately 70 and 90%, respectively. Collecting a 24 hour urine specimen is difficult and inconvenient for patients and increases analytical variability. In addition, serotonin-containing foods may i...

ea0036oc7.1 | Oral Communications 7 | BSPED2014

Additional professional support for paediatric patients with diabetes mellitus: are we targeting the right patients?

Wei Christina , Marr Tim , Alston Aileen , Riasz-Teeluck Tasneem , Bain Murray

Introduction: Outcomes of the National Paediatric Diabetes Audit have shown that patients of Black ethnic origin have poorer glycaemic control. Additional professional contacts mandated by the Best Practice Tariff aim to improve glycaemic control in paediatric patients with diabetes mellitus, but do not allow for differing needs.Aim: To evaluate whether additional professional support for paediatric diabetic patients are targeted at those with worst glyc...

ea0061cd2.2 | Case Discussions: complex clinical cases 2.0 | OU2019

Simultaneous islet cell and kidney transplant in a patient with Type 1 Diabetes and End-Stage Renal Failure after Roux-en-Y gastric bypass

Lim Jonathan ZM , Rutter Martin K , Wilding John PH

Background: Severe obesity, BMI ≥40 kg/m2, confers a greater risk for graft loss and mortality among renal transplant patients. Transplantation provides a better survival and quality of life in overweight dialysis patients. Higher BMI is associated with progressively increased risk of CKD stages 4–5, hazard ratio of 3.10 (CI 2.95–3.25) for BMI ≥35 kg/m2. A recent meta-analysis found pre-transplant BMI <30 kg/m2 is asso...

ea0060p18 | (1) | UKINETS2018

The impact of 68Ga-based PET-CT scanning on the management of patients with sporadic pancreatic neuroendocrine tumours (pNETs)

Cuthbertson Daniel , Barriuso Jorge , Pizanais Michail , Jaffa Matthew , Lamarca Angela , Vivian Gillian , Halloran Tom , Westwood Tom , Prachalias Andreas , O'Reilly Derek , Weismann Hulya , Martin Wendy , Vinjamuri Sobhan , Pritchard D Mark , Hubner Richard , Srirajaskanthan Raj , Ramage John , Raraty Mike , Ganeh Paula , Fenwick Steve , Valle Juan , Yip Vincent

Background: Pancreatic neuroendocrine tumours (panNETs) are rare tumours (prevalence 4/100,000). Diagnosis and staging of panNETs requires biochemical screening, cross-sectional imaging (with CT/MRI), endoscopic ultrasound (EUS) and where available, functional imaging using 68Ga-labelled synthetic octreotide analogues using PET-CT due to its reported higher sensitivity and specificity.Methods: A retrospective, electronic case note study was ca...

ea0060p30 | (1) | UKINETS2018

The impact of 68Ga-based PET-CT scanning on the management of patients with familial pancreatic neuroendocrine tumours (panNETs)

Cuthbertson Daniel , Barriuso Jorge , Pizanias Michail , Jaffa Matthew , Nuttall Christina , Vivian Gillian , Halloran Tom , Westwood Tom , Prachalias Andreas , Lalloo Fiona , Weismann Hulya , Martin Wendy , Vinjamuri Sobhan , Mark Pritchard D. , Fenwick Steve , Ganeh Paula , Raraty Mike , McNamara Mairead , Srirajaskanthan Raj , Ramage John , Manoharan Prakash , Yip Vincent

Background: Pancreatic neuroendocrine tumours (panNETs) may arise as part of an underlying genetic condition such as multiple endocrine neoplasia type 1 (MEN type 1). The value of functional imaging using 68Ga-labelled synthetic octreotide analogues using PET-CT has not been extensively evaluated in patients with MEN1 to determine its value.Methods: We investigated the effect of 68Ga-based PET-CT imaging on patient management in pat...

ea0058oc7.4 | Oral Communications 7 | BSPED2018

Parental language proficiency and glycaemic control in children with type 1 diabetes

Jackson Charlotte , Rutherford Fiona , Shakesheff Megan , Pinchin Fiona , Bain Murray , Wei Christina

Introduction: Effective communication between care providers and parents/carers is fundamental for the management of children with Type 1 diabetes. National guidelines highlight the importance of communicating effectively with parents of limited understanding of English. This study evaluates whether parental language proficiency is related to glycaemic control in a paediatric diabetes clinic serving an inner city multi-ethnic population.Method: Routine d...